Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares were up 1% on Friday . The company traded as high as $3.88 and last traded at $3.88. Approximately 709,358 shares changed hands during trading, an increase of 304% from the average daily volume of 175,661 shares. The stock had previously closed at $3.84.
Ono Pharmaceutical Stock Performance
The firm has a fifty day moving average price of $4.34 and a two-hundred day moving average price of $4.60.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
See Also
- Five stocks we like better than Ono Pharmaceutical
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Invest in Insurance Companies: A Guide
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is the FTSE 100 index?
- Time to Load Up on Home Builders?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
